Alnylam Pharmaceuticals, Inc Earning Date (ALNY)

USA |NASDAQ |USD

ALNY Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Oct 26, 2022 Sep 2022 $-1.68 - $-1.72
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Oct 26, 2022 Sep 2022 $286.11M - $187.63M

Alnylam Pharmaceuticals, Inc's next earnings date is Wednesday, Oct 26, 2022 for the fiscal quarter ending Sep 2022.

ALNY Earnings Date & History Chart

ALNY Earnings & Revenue Forecast

ALNY Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 19 $-1.68 $-2.27 $-1.11
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 22 $-6.82 $-9.13 $-4.10
Dec 2023 19 $-3.43 $-8.04 $1.12

ALNY Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Sep 2022 1 / 0 $-1.62 $-1.62 $-1.56
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 0 $-6.56 $-6.45 $-6.27
Dec 2023 2 / 0 $-3.23 $-2.93 $-3.13

ALNY Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Sep 2022 18 $286.11M $264.30M $311.20M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 24 $1.09B $1.01B $1.13B
Dec 2023 23 $1.62B $1.31B $2.28B

ALNY Earnings Date & Revenue History

ALNY Earnings History

|
Show More
Show More

ALNY Revenue History

|
Show More
Show More

Alnylam Pharmaceuticals, Inc Next Earnings Date & Report

ALNY Next Earnings Date & Report Preview: Sep 2022 (FQ)

ALNY's next earnings date is Wednesday, Oct 26, 2022 for the fiscal quarter ending Sep 30, 2022.

According to analysts, the average EPS estimation for Alnylam Pharmaceuticals, Inc's next quarterly earnings is $-1.68, with a low EPS estimation of $-2.27, and a high estimation of $-1.11.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-1.62, the last 2 month trend is $-1.62, and the 3 month trend is $-1.56.

Based on analysts, the average revenue estimation is $286.11M, with a low revenue estimation of $264.30M, and a high estimation of $311.20M.

Alnylam Pharmaceuticals, Inc Previous Earnings Dates & Reports

ALNY Previous Earnings Date & Report Recap: Jun 2022 (FQ)

Alnylam Pharmaceuticals, Inc's previous earnings date was Jul 28, 2022 for its fiscal quarter ended Jun 30, 2022.

ALNY Previous Earnings Date & Report Recap: Dec 2021 (FY)

Alnylam Pharmaceuticals, Inc's previous annual earnings date was Feb 10, 2022 for its fiscal year ended Dec 31, 2021.

ALNY's earnings per share (EPS) was $-7.20, missing the consensus analysts forecast of $-6.47 by 11.28% , and higher than the previous year's EPS (Dec 2020) by -3.36%.

Revenues were $844.29M, better than the forecast of $821.70M by 2.75%, and up by 71.31% from previous year's revenue.

The company reported a net income of $-852.82M.

Alnylam Pharmaceuticals, Inc reported a free cash flow of $-628.09M for its fiscal year, compared to $-685.32M a year ago.

The company ended the fiscal year with $1.28B in total debt, an increase of 145.39% compared to the previous year.